← all drugs
Methylprednisolone Acetate Injection
in shortage · Rheumatology · Snapshot: 2026-10-09
Day 1,759
of this shortage, counting from the FDA's first posting on 12/15/2021
- Manufacturers listed
- Pfizer Inc., Sagent Pharmaceuticals, Amneal Pharmaceuticals, Eugia US LLC, Par Health, USA LLC
- Reported reason(s)
- Demand increase for the drug; Shortage of an active ingredient; Other
- Machine-readable
- JSON for this drug
Presentations (23)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Pfizer Inc. | Unavailable | 09/21/2026 |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) | Sagent Pharmaceuticals | Unavailable | 09/18/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Pfizer Inc. | Available | 09/21/2026 |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Pfizer Inc. | Available | 09/21/2026 |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5) | Amneal Pharmaceuticals | Available | 06/17/2026 |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Pfizer Inc. | Limited Availability | 09/21/2026 |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) | Sagent Pharmaceuticals | Unavailable | 09/18/2026 |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1) | Amneal Pharmaceuticals | Available | 06/17/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Pfizer Inc. | Unavailable | 09/21/2026 |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1) | Amneal Pharmaceuticals | Limited Availability | 06/17/2026 |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5) | Amneal Pharmaceuticals | Available | 06/17/2026 |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Pfizer Inc. | Limited Availability | 09/21/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Pfizer Inc. | Available | 09/21/2026 |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) | Eugia US LLC | Unavailable | 10/02/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Pfizer Inc. | Limited Availability | 09/21/2026 |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Pfizer Inc. | Available | 09/21/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Pfizer Inc. | Limited Availability | 09/21/2026 |
| Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Pfizer Inc. | Available | 09/21/2026 |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) | Eugia US LLC | Unavailable | 10/02/2026 |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) | Sagent Pharmaceuticals | Limited Availability | 09/18/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Pfizer Inc. | Limited Availability | 09/21/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Pfizer Inc. | Available | 09/21/2026 |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) | Par Health, USA LLC | Unavailable | 10/02/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-23 — Methylprednisolone Acetate Injection: availability wording revised for 1 presentation(s)
- 2026-08-26 — Methylprednisolone Acetate Injection: availability wording revised for 1 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.